Galen acquires Nordic-based POA Pharma in multi-million pound deal
Northern Ireland-based, globally focused pharmaceutical sales and marketing firm Galen has acquired Swedish-headquartered POA Pharma...
Read More...
Focus:
Sweden
-
![Cobra Biologics Manufacturing Facility Expansion, Matfors]()
Cobra Biologics Manufacturing Facility Expansion, Matfors
Cobra Biologics, a contract development and manufacturing organisation (CDMO), is expanding its manufacturing facility located...
Read More...
-
Sobi to purchase Dova Pharmaceuticals in $915m deal
Swedish Orphan Biovitrum AB (Sobi) has agreed to acquire US-based Dova Pharmaceuticals in a transaction...
Read More...
-
Moberg Pharma signs deal with Taisho for MOB-015 development
Swedish company Moberg Pharma has signed an agreement with Taisho Pharmaceutical towards the development, registration...
Read More...
-
![Alligator Bioscience regains cancer asset rights from Janssen]()
Alligator Bioscience regains cancer asset rights from Janssen
Swedish biotech firm Alligator Bioscience has regained the global rights for tumour-directed immunotherapy ADC-1013 (JNJ-64457107)...
Read More...
-
![Sobi to acquire emapalumab drug from Novimmune]()
Sobi to acquire emapalumab drug from Novimmune
Swedish Orphan Biovitrum (Sobi) has agreed to buy a newly established firm from Novimmune for...
Read More...
-
![Biomedicum research laboratory]()
Biomedicum Research Laboratory, Karolinska Institute
Biomedicum is one of the largest experimental biomedical research laboratories in Europe.
Read More...
-
Deals this week: Medicines for Malaria Venture, Swedish Orphan Biovitrum, aTyr Pharma
Medicines for Malaria Venture (MMV) has entered a collaboration with Drugs for Neglected Disease initiative...
Read More...
-
AstraZeneca divests Synagis US rights to Sobi for $1.6bn
Swedish Orphan Biovitrum (Sobi) has completed the acquisition of US rights to AstraZeneca’s Synagis (palivizumab)...
Read More...
-
Deals and M&As this week: EQT, Sanofi, Bristol-Myers Squibb
EQT has agreed to increase its acquisition offer for Karo Pharma to Skr6.15bn ($694m) through...
Read More...
Close
Close
Close
Go Top